Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetes.

Failure to reach target glycated a1c levels among patients with diabetes who are adherent to their antidiabetic medication. Popul Health Manag (2014) 0.75

Appointment keeping for medical review among patients with selected chronic diseases in an urban area of Uganda. Pan Afr Med J (2014) 0.75

The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care (2012) 2.33

Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation (2007) 3.88

β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care (2012) 1.66

Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery (2007) 1.18

Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes. J Investig Med (2007) 1.02

Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care (2012) 0.97

Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs. J Investig Med (2013) 0.87

Thyrotropin-secreting adenoma in a patient with primary hypothyroidism. Endocr Pract (2011) 0.85

Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. Expert Rev Cardiovasc Ther (2011) 0.84

Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges. Curr Cardiol Rep (2015) 0.81

Brief report: depression and history of suicide attempts in adults with new-onset Type 2 Diabetes. Psychoneuroendocrinology (2013) 0.80

Random blood glucose: a robust risk factor for type 2 diabetes. J Clin Endocrinol Metab (2015) 0.77

Response to Comment on: Harrison et al. β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 2012;35:1406-1412. Diabetes Care (2013) 0.75

Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial. J Investig Med (2014) 0.75

SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUO. Endocr Pract (2017) 0.75

Is insulin treatment a first-line defense against Type 2 diabetes? Expert Rev Cardiovasc Ther (2010) 0.75

Sweet's syndrome and subacute thyroiditis: an unrecognized association? Thyroid (2010) 0.75